Endoplasmic reticulum-associated degradation-induced dissociation of class II invariant chain complexes containing a glycosylation-deficient form of p41

Journal of Immunology

Volumn 173, Issue 4, 2004, Pages 2586-2593

  Sevilla, Lisa M ^a,c   Comstock, Sarah S ^a   Swier, Kevin ^a,d   Miller, Jim ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d CHICAGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE; MANNOSIDASE; MANNOSIDASE 1; OLIGOMERIC PROTEIN; POLYPEPTIDE; PROTEASOME; PROTEIN; PROTEIN P41; PROTEIN SEC61; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOL; ENDOPLASMIC RETICULUM; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN MISFOLDING; PROTEIN TARGETING; PROTEIN UNFOLDING; TRIMERIZATION;

EID: 4043111286     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.4.2586     Document Type: Article

References (55)

1. Rudd, P. M., T. Elliott, P. Cresswell, I. A. Wilson, and R. A. Dwek. 2001. Glycosylation and the immune system. Science 291:2370.
2. Ellgaard, L., and A. Helenius. 2003. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4:181.
3. Helenius, A., and M. Aebi. 2001. Intracellular functions of N-linked glycans. Science 291:2364.
4. Hammond, C., I. Braakman, and A. Helenius. 1994. Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc. Natl. Acad. Sci. USA 91:913.
5. Cannon, K. S., and A. Helenius. 1999. Trimming and readdition of glucose to N-linked oligosaccharides determines calnexin association of a substrate glycoprotein in living cells. J. Biol. Chem. 274:7537.
6. Trombetta, E. S., and A. Helenius. 2000. Conformational requirements for glycoprotein reglucosylation in the endoplasmic reticulum. J. Cell Biol. 148:1123.
7. Wiertz, E. J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T. R. Jones, T. A. Rapoport, and H. L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432.
8. Hughes, E. A., C. Hammond, and P. Cresswell. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA 94:1896.
9. Huppa, J. B., and H. L. Ploegh. 1997. The a chain of the T cell antigen receptor is degraded in the cytosol. Immunity 7:113.
10. Kostova, Z., and D. H. Wolf. 2003. For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection. EMBO J. 22:2309.
11. Bonifacino, J. S., and A. M. Weissman. 1998. Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu. Rev. Cell Dev. Biol. 14:19.
12. Tokunaga, F., C. Brostrom, T. Koide, and P. Arvan. 2000. Endoplasmic reticulum (ER)-associated degradation of misfolded N-linked glycoproteins is suppressed upon inhibition of ER mannosidase I. J. Biol. Chem. 275:40757.
13. Hosokawa, N., I. Wada, K. Hasegawa, T. Yorihuzi, L. O. Tremblay, A. Herscovics, and K. Nagata. 2001. A novel ER α-mannosidase-like protein accelerates ER-associated degradation. EMBO Rep. 2:415.
14. Belbeoc'h, S., J. Massoulie, and S. Bon. 2003. The C-terminal T peptide of acetylcholinesterase enhances degradation of unassembled active subunits through the ERAD pathway. EMBO J. 22:3536.
15. Molinari, M., V. Calanca, C. Galli, P. Lucca, and P. Paganetti. 2003. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science 299:1397.
16. Oda, Y., N. Hosokawa, I. Wada, and K. Nagata. 2003. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science 299:1394.
17. Hiltbold, E. M., and P. A. Roche. 2002. Trafficking of MHC class II molecules in the late secretory pathway. Curr. Opin. Cell Biol. 14:30.
18. Stumptner-Cuvelette, P., and P. Benaroch. 2002. Multiple roles of the invariant chain in MHC class II function. Biochim. Biophys. Acta 1542:1.
19. Ashman, J. B., and J. Miller. 1999. A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain. J. Immunol. 163:2704.
20. Bijlmakers, M.-J. E., P. Benaroch, and H. L. Ploegh. 1994. Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med. 180:623.
21. Gedde-Dahl, M., I. Freisewinkel, M. Staschewski, K. Schenck, N. Koch, and O. Bakke. 1997. Exon 6 is essential for invariant chain trimerization and induction of large endosomal structures. J. Biol. Chem. 272:8281.
22. Castellino, F., R. Han, and R. N. Germain. 2001. The transmembrane segment of invariant chain mediates binding to MHC class II molecules in a CLIP-independent manner. Eur. J. Immunol. 31:841.
23. Roche, P. A. 1996. Out damned CLIP! Out, I say! Science 274:526.
24. Cresswell, P. 1996. Invariant chain structure and MHC class II function. Cell 84:505.
25. Pieters, J., O. Bakke, and B. Dobberstein. 1993. The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J. Cell Sci. 106:831.
26. Bremnes, B., T. Madsen, M. Gedde-Dahl, and O. Bakke. 1994. An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization. J. Cell Sci. 107:2021.
27. Odorizzi, C. G., I. S. Trowbridge, L. Xue, C. R. Hopkins, C. D. Davis, and J. F. Collawn. 1994. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J. Cell Biol. 126:317.
28. Pond, L., L. A. Kuhn, L. Teyton, M. P. Schutze, J. A. Tainer, M. R. Jackson, and P. A. Peterson. 1995. A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway. J. Biol. Chem. 270:19989.
29. Fineschi, B., K. Sakaguchi, E. Appella, and J. Miller. 1996. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain. J. Immunol. 157:3211.
30. Bevec, T., V. Stoka, G. Pungercic, I. Dolenc, and V. Turk. 1996. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. 183:1331.
31. Lenarcic, B., and T. Bevec. 1998. Thyropins: new structurally related proteinase inhibitors. Biol. Chem. 379:105.
32. Miller, J., and R. N. Germain. 1986. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J. Exp. Med. 164:1478.
33. Peterson, M., and J. Miller. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 357:596.
34. Mehringer, J. H., M. R. Harris, C. S. Kindle, D. W. McCourt, and S. E. Cullen. 1991. Characterization of fragments of the murine Ia-associated invariant chain. J. Immunol. 146:920.
35. Koch, N., G. Hammerling, N. Tada, S. Kimura, and U. Hammerling. 1982. Cross-blocking studies with monoclonal antibodies against I-A molecules of haplotypes b, d, and k. Eur. J. Immunol. 12:909.
36. Oi, V., P. Jones, J. Goding, L. Herzenberg, and L. Herzenberg. 1978. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr. Top. Microbiol. Immunol. 81:115.
37. Peterson, M., and J. Miller. 1990. Invariant chain influences the immunological recognition of MHC class II molecules. Nature 345:172.
38. Arneson, L. S., and J. Miller. 1995. Efficient endosomal localization of major histocompatibility complex class II-invariant chain complexes requires multimerization of the invariant chain targeting sequence. J. Cell Biol. 129:1217.
39. Anderson, M. S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:2282.
40. + T cell development. Immunity 3:359.
41. Sedwick, C. E., M. M. Morgan, L. Jusino, J. L. Cannon, J. Miller, and J. K. Burkhardt. 1999. TCR, LFA-1, and CD28 play unique and complementary roles in signaling T cell cytoskeletal reorganization. J. Immunol. 162:1367.
42. Braakman, I., J. Helenius, and A. Helenius. 1992. Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum. EMBO J. 11:1717.
43. Caldwell, S. R., K. J. Hill, and A. A. Cooper. 2001. Degradation of endoplasmic reticulum (ER) quality control substrates requires transport between the ER and Golgi. J. Biol. Chem. 276:23296.
44. Vashist, S., W. Kim, W. J. Belden, E. D. Spear, C. Barlowe, and D. T. Ng. 2001. Distinct retrieval and retention mechanisms are required for the quality control of endoplasmic reticulum protein folding. J. Cell Biol. 155:355.
45. Taxis, C., F. Vogel, and D. H. Wolf. 2002. ER-Golgi traffic is a prerequisite for efficient ER degradation. Mol. Biol. Cell 13:1806.
46. Yang, M., S. Omura, J. S. Bonifacino, and A. M. Weissman. 1998. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells: importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from membranes. J. Exp. Med. 6:835.
47. Mayer, T., T. Braun, and S. Jentsch. 1998. Role of the proteasome in membrane extraction of a short lived ER transmembrane protein. EMBO J. 17:3251.
48. Zanotti, G., S. Ottonello, R. Berni, and H. L. Monaco. 1993. Crystal structure of the trigonal form of human plasma retinal-binding protein at 2.5 Å resolution. J. Mol. Biol. 230:613.
49. Newcomer, M. 1995. Retinoid-binding proteins: structural determinants important for function. FASEB J. 9:229.
50. Guncar, G., G. Pungercic, I. Klemencic, V. Turk, and D. Turk. 1999. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J. 18:793.
51. Chiva, C., P. Barthe, A. Codina, M. Gairi, F. Molina, C. Granier, M. Pugniere, T. Inui, H. Nishio, Y. Nishiuchi, et al. 2003. Synthesis and NMR structure of p41icf, a potent inhibitor of human cathepsin L. J. Am. Chem. Soc. 125:1508.
52. Liu, Y., P. Choudhury, C. M. Cabral, and R. N. Sifers. 1999. Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J. Biol. Chem. 274:5861.
53. Wang, J., and A. L. White. 2000. Role of calnexin, calreticulin, and endoplasmic reticulum mannosidase I in apolipoprotein(a) intracellular targeting. Biochemistry 39:8993.
54. 2-plasmin inhibitor for degradation by the proteasome. J. Biol. Chem. 275:4981.
55. Tirosh, B., M. H. Furman, D. Tortorella, and H. L. Ploegh. 2003. Protein unfolding is not a prerequisite for endoplasmic reticulum-to-cytosol dislocation. J. Biol. Chem. 278:6664.